PTHLH and triple-negative breast carcinoma: Suppression of PTHrP expression has been shown to be a promising approach for anti-cancer strategies in chondrosarcoma, thyroid cancer, medulloblastoma, adrenocortical cancer, oral squamous, renal, colon, prostate, and triple-negative breast cancer cells (reviewed in [109,110]).